Seeking to develop rules to govern the use of nanomaterials in medical devices, the research arm of the European Commission is asking for input from anyone who has worked with the materials and observed problems.

The FDA has cleared Siemens Healthcare's Somatom Definition Flash dual-source CT system with the Stellar Detector for sale and distribution in the U.S.

The FDA has approved the first generic versions of irbesartan (Avapro) and irbesartan/hydrochlorothiazide (Avalide) tablets for the treatment of high blood pressure.

The department of radiology at the University of Colorado School Of Medicine in Denver has developed a pocket-sized reference card to communicate the effective doses and radiation risks of common adult imaging studies, according to an update published in the April issue of the Journal of the American College of Radiology.

A study, which breast imaging stakeholders have characterized as underpowered and statistically sloppy, has concluded that 15 to 25 percent of breast cancer cases diagnosed in the Norwegian Screening Program are overdiagnosed, according to research published April 3 in Annals of Internal Medicine. These study results run counter to published data about organized screening programs, which report up to a 40 percent decrease in the death rate among women who participate in screening, Michael N. Linver, MD, director of mammography at X-Ray Associates of New Mexico in Albuquerque, told Health Imaging.

GE Healthcare and Dyax have signed a licensing agreement for the development and commercialization of peptides binding to c-Met, which provides upfront, milestone and royalty payments to Dyax. The license includes application of the peptides in PET, SPECT and optical imaging.

Breast cancer patients treated with intensity modulated radiation therapy (IMRT) instead of standard whole breast irradiation (WBI) have a lower incidence of acute or chronic toxicities, according to a study in Practical Radiation Oncology.

Johns Hopkins Medicine is almost ready to replace much of its main hospital campus in Baltimore with a $1.1 billion, 1.6-million-square-foot facility next door.